VERMOX is a Oral Tablet, Chewable in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Mebendazole.
Product ID | 50458-675_086f72d0-a9b6-46ea-ac0d-53a4999fa3a2 |
NDC | 50458-675 |
Product Type | Human Prescription Drug |
Proprietary Name | VERMOX |
Generic Name | Mebendazole |
Dosage Form | Tablet, Chewable |
Route of Administration | ORAL |
Marketing Start Date | 2016-10-20 |
Marketing Category | NDA / NDA |
Application Number | NDA208398 |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Substance Name | MEBENDAZOLE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Anthelmintic [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2016-10-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208398 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-10-20 |
Ingredient | Strength |
---|---|
MEBENDAZOLE | 500 mg/1 |
SPL SET ID: | a720c424-517a-461b-8e13-6c37caf8aa3f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
50458-675 | VERMOX | mebendazole |
50580-070 | VERMOX | mebendazole |
64896-669 | Emverm | mebendazole |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VERMOX 86870940 not registered Live/Pending |
Johnson & Johnson 2016-01-11 |
VERMOX 86065978 not registered Live/Pending |
Zylera Pharmaceuticals LLC 2013-09-16 |
VERMOX 85833992 not registered Dead/Abandoned |
JOHNSON & JOHNSON 2013-01-28 |
VERMOX 73362222 1261438 Dead/Cancelled |
Johnson & Johnson 1982-04-29 |